In collaboration with the National Hemophilia Foundation (NHF), the European Haemophilia Consortium (EHC), and Medscape Education, the World Federation of Hemophilia (WFH) is developing a continuing medical education (CME) curriculum, designed for clinicians but available to everyone, to provide introductory information on gene therapy in hemophilia.
The CME curriculum is made up of five online activities that will roll out over several months, sequentially, beginning in May 2018. While clinicians can qualify for CME credits all learners can obtain a completion certificate, or explore the activity to enhance your knowledge of gene therapy in hemophilia. The first activity, Test Your Knowledge of Gene Therapy in Hemophilia, is an educational self-assessment survey and is now live. The questions allow you to see how much you already know about gene therapy in hemophilia and the answers explain the essential information required for a fuller understanding. Click the View Resource button to access the activity through the Medscape site, there you will have to register, which is free and straightforward.
Other activities coming soon in this curriculum include expert discussions on the background and science behind gene therapy in hemophilia, and a clinical article describing recent advances in gene therapy clinical trials in hemophilia.
Visit this page frequently to access each new learning activity in the curriculum as they go live over the next few months!